Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019

This economic evaluation study assesses the clinical benefit of novel drugs approved in 2018 and 2019 and examines whether drugs approved with special regulatory designations appear to provide meaningful therapeutic value.

Detalles Bibliográficos
Autores principales: Vokinger, Kerstin N., Hwang, Thomas J., Glaus, Camille E. G., Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987900/
https://www.ncbi.nlm.nih.gov/pubmed/35385091
http://dx.doi.org/10.1001/jamanetworkopen.2022.6479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987900/
https://www.ncbi.nlm.nih.gov/pubmed/35385091
http://dx.doi.org/10.1001/jamanetworkopen.2022.6479

Ejemplares similares